©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Biol Chem. Feb 26, 2017; 8(1): 81-85
Published online Feb 26, 2017. doi: 10.4331/wjbc.v8.i1.81
Published online Feb 26, 2017. doi: 10.4331/wjbc.v8.i1.81
Use of thyroglobulin as a tumour marker
Buddhike Sri Harsha Indrasena, Consultant General and Endocrine Surgeon, Kandy General Hospital (Teaching), Kandy 20000, Sri Lanka
Author contributions: Indrasena BSH performed the whole of the writing.
Conflict-of-interest statement: None.
Correspondence to: Buddhike Sri Harsha Indrasena, MBBS (Hons), MS (Surgery), MSc (Statistics), MRCS(Ed), Consultant General and Endocrine Surgeon, Kandy General Hospital (Teaching), William Gopallawa Mawatha, Kandy 20000, Sri Lanka. indrasenaharsha@gmail.com
Telephone: +94-718-713457 Fax: +94-812-233343
Received: September 28, 2016
Peer-review started: October 7, 2016
First decision: November 10, 2016
Revised: December 28, 2016
Accepted: January 11, 2017
Article in press: January 14, 2017
Published online: February 26, 2017
Processing time: 149 Days and 15.7 Hours
Peer-review started: October 7, 2016
First decision: November 10, 2016
Revised: December 28, 2016
Accepted: January 11, 2017
Article in press: January 14, 2017
Published online: February 26, 2017
Processing time: 149 Days and 15.7 Hours
Core Tip
Core tip: Although serum thyroglobulin (TG) is widely used as a tool to detect recurrence of thyroid cancer, it is widely held that preoperative TG measurement is unnecessary. It is true that preoperative TG level is hardly of much diagnostic value, but without a preoperative TG report, it is not possible to safely utilize serial serum TG subsequently as a monitoring tool. Routine measurement of serum TG before surgery is, therefore, recommended.